2014 Q3 Form 10-Q Financial Statement
#000156459014005289 Filed on November 07, 2014
Income Statement
| Concept | 2014 Q3 | 2013 Q3 |
|---|---|---|
| Revenue | $12.71M | $12.35M |
| YoY Change | 2.95% | -10.38% |
| Cost Of Revenue | $7.400M | $8.610M |
| YoY Change | -14.05% | 14.8% |
| Gross Profit | $5.320M | $3.740M |
| YoY Change | 42.25% | -40.46% |
| Gross Profit Margin | 41.84% | 30.28% |
| Selling, General & Admin | $6.360M | $6.370M |
| YoY Change | -0.16% | 16.37% |
| % of Gross Profit | 119.55% | 170.32% |
| Research & Development | $1.276M | $980.0K |
| YoY Change | 30.2% | -17.99% |
| % of Gross Profit | 23.98% | 26.2% |
| Depreciation & Amortization | $160.0K | $140.0K |
| YoY Change | 14.29% | 16.67% |
| % of Gross Profit | 3.01% | 3.74% |
| Operating Expenses | $8.688M | $7.350M |
| YoY Change | 18.2% | 10.21% |
| Operating Profit | -$3.368M | -$3.610M |
| YoY Change | -6.7% | 830.41% |
| Interest Expense | -$170.0K | -$170.0K |
| YoY Change | 0.0% | -273.47% |
| % of Operating Profit | ||
| Other Income/Expense, Net | -$172.0K | -$166.0K |
| YoY Change | 3.61% | 31.75% |
| Pretax Income | -$3.467M | -$4.027M |
| YoY Change | -13.91% | 683.46% |
| Income Tax | $28.00K | $22.00K |
| % Of Pretax Income | ||
| Net Earnings | -$3.495M | -$4.049M |
| YoY Change | -13.68% | 638.87% |
| Net Earnings / Revenue | -27.49% | -32.79% |
| Basic Earnings Per Share | -$0.08 | -$0.12 |
| Diluted Earnings Per Share | -$0.08 | -$0.12 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 42.40M | 32.73M |
| Diluted Shares Outstanding | 42.40M | 32.73M |
Balance Sheet
| Concept | 2014 Q3 | 2013 Q3 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $2.760M | $4.150M |
| YoY Change | -33.49% | 219.23% |
| Cash & Equivalents | $2.760M | $4.151M |
| Short-Term Investments | ||
| Other Short-Term Assets | $1.290M | $1.060M |
| YoY Change | 21.7% | 0.0% |
| Inventory | $11.80M | $11.75M |
| Prepaid Expenses | ||
| Receivables | $9.260M | $10.80M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $25.11M | $27.76M |
| YoY Change | -9.55% | 16.35% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $1.470M | $1.710M |
| YoY Change | -14.04% | 13.92% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $270.0K | $260.0K |
| YoY Change | 3.85% | -26.97% |
| Total Long-Term Assets | $4.790M | $5.100M |
| YoY Change | -6.08% | 3.98% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $25.11M | $27.76M |
| Total Long-Term Assets | $4.790M | $5.100M |
| Total Assets | $29.90M | $32.86M |
| YoY Change | -9.01% | 14.24% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $9.535M | $9.350M |
| YoY Change | 1.98% | 30.17% |
| Accrued Expenses | $5.697M | $3.970M |
| YoY Change | 43.5% | -21.25% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $5.530M |
| YoY Change | -100.0% | 152.51% |
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $17.77M | $22.72M |
| YoY Change | -21.77% | 28.69% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $370.0K | $30.00K |
| YoY Change | 1133.33% | -78.87% |
| Total Long-Term Liabilities | $370.0K | $30.00K |
| YoY Change | 1133.33% | -78.87% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $17.77M | $22.72M |
| Total Long-Term Liabilities | $370.0K | $30.00K |
| Total Liabilities | $18.80M | $23.36M |
| YoY Change | -19.52% | 26.62% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | $1.964M | |
| Shareholders Equity | $11.10M | $9.500M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $29.90M | $32.86M |
| YoY Change | -9.01% | 14.24% |
Cashflow Statement
| Concept | 2014 Q3 | 2013 Q3 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$3.495M | -$4.049M |
| YoY Change | -13.68% | 638.87% |
| Depreciation, Depletion And Amortization | $160.0K | $140.0K |
| YoY Change | 14.29% | 16.67% |
| Cash From Operating Activities | -$7.370M | -$1.990M |
| YoY Change | 270.35% | 665.38% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$70.00K | -$130.0K |
| YoY Change | -46.15% | -50.0% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $0.00 | $0.00 |
| YoY Change | -100.0% | |
| Cash From Investing Activities | -$70.00K | -$130.0K |
| YoY Change | -46.15% | 0.0% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $11.50M | |
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 8.250M | 4.110M |
| YoY Change | 100.73% | 10175.0% |
| NET CHANGE | ||
| Cash From Operating Activities | -7.370M | -1.990M |
| Cash From Investing Activities | -70.00K | -130.0K |
| Cash From Financing Activities | 8.250M | 4.110M |
| Net Change In Cash | 810.0K | 1.990M |
| YoY Change | -59.3% | -668.57% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$7.370M | -$1.990M |
| Capital Expenditures | -$70.00K | -$130.0K |
| Free Cash Flow | -$7.300M | -$1.860M |
| YoY Change | 292.47% | -1597727834112000000.0% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2014Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
9535000 | |
| CY2014Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
5697000 | |
| CY2014Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
17774000 | |
| CY2014Q3 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
662000 | |
| CY2014Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3668000 | |
| CY2014Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3495000 | |
| CY2013Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3961000 | |
| CY2013Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
88000 | |
| CY2014Q3 | us-gaap |
Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
|
367000 | |
| CY2014Q3 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
2431000 | |
| CY2013Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-166000 | |
| CY2014Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-172000 | |
| CY2013Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
22000 | |
| CY2014Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-173000 | |
| CY2013Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4049000 | |
| CY2014Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
28000 | |
| CY2014Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
8688000 | |
| CY2013Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
1000 | |
| CY2014Q3 | us-gaap |
Customer Deposits Current
CustomerDepositsCurrent
|
111000 | |
| CY2014Q3 | us-gaap |
Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
|
11099000 | |
| us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
152000 | ||
| CY2014Q3 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
37000 | |
| CY2013Q3 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
182000 | |
| us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
452000 | ||
| us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
386000 | ||
| CY2014Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-3467000 | |
| CY2013Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-4027000 | |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-14740000 | ||
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-9430000 | ||
| CY2014Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.08 | |
| CY2013Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.12 | |
| CY2014Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.08 | |
| CY2013Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.12 | |
| CY2014Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
42403000 | |
| CY2013Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
32734000 | |
| CY2014Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
42403000 | |
| CY2013Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
32734000 | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
529000 | ||
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
439000 | ||
| us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
1000 | ||
| us-gaap |
Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
|
796000 | ||
| us-gaap |
Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
|
270000 | ||
| us-gaap |
Inventory Write Down
InventoryWriteDown
|
261000 | ||
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
200000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1239000 | ||
| us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
64000 | ||
| us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-187000 | ||
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-61000 | ||
| us-gaap |
Inventory Write Down
InventoryWriteDown
|
1000000 | ||
| CY2014Q3 | biol |
Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
|
12000000 | |
| CY2014Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
11500000 | |
| CY2014Q3 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
491000 | |
| CY2014Q3 | us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
2900000 | |
| us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
9162000 | ||
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1608000 | ||
| us-gaap |
Interest Paid
InterestPaid
|
165000 | ||
| us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
51000 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.90 | ||
| CY2014Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
273000 | |
| CY2014Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4703000 | |
| us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
34000 | ||
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
16302000 | ||
| CY2014Q3 | biol |
Share Based Compensation Net Impact On Earning Per Share Diluted
ShareBasedCompensationNetImpactOnEarningPerShareDiluted
|
-0.01 | |
| us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
10000 | ||
| us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
16875000 | ||
| us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
27300000 | ||
| us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
21508000 | ||
| biol |
Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
|
707000 | ||
| CY2013Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4151000 | |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">The preparation of these consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect amounts reported in the consolidated financial statements and the accompanying notes. Significant estimates in these consolidated financial statements include allowances on accounts receivable, inventory, and deferred taxes, as well as estimates for accrued warranty expenses, indefinite-lived intangible assets, and the ability of goodwill to be realized, revenue deferrals for multiple element arrangements, effects of stock-based compensation and warrants, contingent liabilities, and the provision or benefit for income taxes. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may differ materially from those estimates. </p></div> | ||
| CY2014Q4 | biol |
Term Of Warrant
TermOfWarrant
|
P3Y | |
| CY2013Q3 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
1330000 | |
| biol |
Recent Accounting Pronouncements Policy Text B Lock
RecentAccountingPronouncementsPolicyTextBLock
|
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates (“ASU’s”) to the FASB’s Accounting Standards Codification (“ASC”). </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers the applicability and impact of all ASU’s. ASU’s not listed below were assessed and determined to not be applicable or are expected to have minimal impact on the Company’s consolidated financial position and results of operations. </p> <p style="margin-bottom:0pt;margin-top:18pt;margin-left:5.22%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Recently Issued Accounting Standards </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (ASU 2014-09), which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The standard is effective for annual periods beginning after December 15, 2016, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). The Company is currently evaluating the impact of the pending adoption of ASU 2014-09 on its consolidated financial statements and has not yet determined the method by which it will adopt the standard during the year ending December 31, 2017.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties About an Entity’s Ability to Continue as a Going Concern. The standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued and provides guidance on determining when and how to disclose going concern uncertainties in the financial statements. Certain disclosures will be required if conditions give rise to substantial doubt about an entity’s ability to continue as a going concern. ASU 2014-15 applies to all entities and is effective for annual and interim reporting periods ending after December 15, 2016, with early adoption permitted. The Company does not expect that the adoption of this standard will have a material effect on its financial statements.</p></div> | ||
| CY2014Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
6250000 | |
| CY2014Q3 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
1.92 | |
| CY2014Q3 | biol |
Share Based Compensation Arrangement By Share Based Payment Award Option Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercised
|
2993000 | |
| CY2014Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3815000 | |
| biol |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividend
|
0 | ||
| CY2014Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
301000 | |
| CY2013Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
491000 | |
| CY2014Q3 | biol |
Share Based Compensation Net Impact On Earning Per Share Basic
ShareBasedCompensationNetImpactOnEarningPerShareBasic
|
-0.01 | |
| CY2014Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
2000000 | |
| us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y1M6D | ||
| CY2014Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P4Y | |
| CY2014Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.8565 | |
| CY2014Q3 | biol |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividend
|
0 | |
| CY2013Q3 | biol |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividend
|
0 | |
| biol |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividend
|
0 | ||
| CY2014Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
4800000 | |
| CY2013Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0154 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0166 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0099 | ||
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4441000 | |
| us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
152000 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
1055000 | ||
| CY2014Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
2485000 | |
| CY2014Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
190000 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.51 | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
2.03 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
4.57 | ||
| CY2014Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.16 | |
| CY2014Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.07 | |
| CY2014Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
5.62 | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y9M29D | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y4M6D | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P2Y5M5D | ||
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1574000 | |
| CY2014Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
815000 | |
| CY2014Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
733000 | |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
310000 | ||
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
707000 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
108000 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
860000 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.62 | ||
| us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | ||
| CY2013Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
437000 | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
921000 | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
1155000 | ||
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4703000 | ||
| CY2013Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6022000 | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6022000 | ||
| CY2014Q3 | biol |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedDescription
|
One-sixth of the stock options and one-sixth of the RSUs vested immediately, with the remaining five-sixths vesting ratably on a monthly basis over the twelve-month period ending on July 13, 2015. | |
| CY2014Q3 | us-gaap |
Treasury Stock Shares Retired
TreasuryStockSharesRetired
|
1963500 | |
| biol |
Annual Stock Dividend Payable Rate
AnnualStockDividendPayableRate
|
0.005 | ||
| us-gaap |
Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
|
2014-03-14 | ||
| CY2014Q3 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
3263000 | |
| CY2013Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
3094000 | |
| CY2014Q3 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
1688000 | |
| CY2013Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
1727000 | |
| CY2014Q3 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
6848000 | |
| CY2013Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
6557000 | |
| CY2014Q3 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
2900000 | |
| CY2013Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
2800000 | |
| CY2014Q3 | biol |
Property Plant And Equipment Gross Excluding Land
PropertyPlantAndEquipmentGrossExcludingLand
|
8713000 | |
| CY2013Q4 | biol |
Property Plant And Equipment Gross Excluding Land
PropertyPlantAndEquipmentGrossExcludingLand
|
8598000 | |
| CY2014Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
7430000 | |
| CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
6971000 | |
| CY2014Q3 | biol |
Property Plant And Equipment Net Excluding Land
PropertyPlantAndEquipmentNetExcludingLand
|
1283000 | |
| CY2013Q4 | biol |
Property Plant And Equipment Net Excluding Land
PropertyPlantAndEquipmentNetExcludingLand
|
1627000 | |
| CY2014Q3 | us-gaap |
Land
Land
|
184000 | |
| CY2013Q4 | us-gaap |
Land
Land
|
199000 | |
| CY2014Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
160000 | |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
477000 | ||
| CY2013Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
124000 | |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
339000 | ||
| CY2014Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
17000 | |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
52000 | ||
| CY2013Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
17000 | |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
100000 | ||
| CY2014Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
2800000 | |
| CY2014Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2669000 | |
| us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | ||
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
2800000 | |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2617000 | |
| CY2013 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | |
| CY2014Q3 | us-gaap |
Goodwill Gross
GoodwillGross
|
2926000 | |
| CY2014Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1852000 | |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1898000 | |
| CY2014Q3 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
999000 | |
| CY2013Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
1096000 | |
| CY2014Q3 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
410000 | |
| CY2013Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
527000 | |
| CY2014Q3 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
2004000 | |
| CY2013Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
912000 | |
| CY2013Q4 | us-gaap |
Accrued Insurance Current
AccruedInsuranceCurrent
|
428000 | |
| CY2014Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
432000 | |
| CY2013Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
136000 | |
| CY2014Q2 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
1255000 | |
| CY2013Q2 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
1518000 | |
| CY2013Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
1096000 | |
| CY2012Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
1699000 | |
| CY2014Q3 | us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
310000 | |
| CY2013Q3 | us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
69000 | |
| us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
919000 | ||
| us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
429000 | ||
| CY2014Q3 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
199000 | |
| CY2013Q3 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
257000 | |
| us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
649000 | ||
| us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
798000 | ||
| CY2014Q3 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
1366000 | |
| CY2013Q3 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
1330000 | |
| CY2013 | biol |
Warranty Period
WarrantyPeriod
|
P1Y | |
| biol |
Warranty Period
WarrantyPeriod
|
P2Y | ||
| CY2014Q3 | biol |
Undelivered Elements Training Installation And Product And Support Services
UndeliveredElementsTrainingInstallationAndProductAndSupportServices
|
892000 | |
| CY2013Q4 | biol |
Undelivered Elements Training Installation And Product And Support Services
UndeliveredElementsTrainingInstallationAndProductAndSupportServices
|
1823000 | |
| CY2014Q3 | us-gaap |
Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
|
1539000 | |
| CY2013Q4 | us-gaap |
Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
|
1642000 | |
| CY2014Q3 | us-gaap |
Deferred Revenue
DeferredRevenue
|
2431000 | |
| CY2013Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
3465000 | |
| CY2013Q4 | us-gaap |
Extended Product Warranty Accrual Noncurrent
ExtendedProductWarrantyAccrualNoncurrent
|
1000 | |
| CY2014Q3 | us-gaap |
Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
|
708000 | |
| us-gaap |
Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
|
708000 | ||
| CY2014Q3 | biol |
Financed Insurance Premium Payable
FinancedInsurancePremiumPayable
|
0 | |
| us-gaap |
Short Term Debt Description
ShortTermDebtDescription
|
Nine | ||
| CY2014Q3 | biol |
Financed Insurance Premium Finance Charge
FinancedInsurancePremiumFinanceCharge
|
0.0285 | |
| CY2014Q3 | us-gaap |
Financing Interest Expense
FinancingInterestExpense
|
0 | |
| us-gaap |
Financing Interest Expense
FinancingInterestExpense
|
2000 | ||
| CY2013Q3 | us-gaap |
Financing Interest Expense
FinancingInterestExpense
|
1000 | |
| us-gaap |
Financing Interest Expense
FinancingInterestExpense
|
5000 | ||
| CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
166000 | |
| CY2014Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
333000 | |
| CY2014Q3 | us-gaap |
Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
|
12900000 | |
| CY2013 | us-gaap |
Payments For Legal Settlements
PaymentsForLegalSettlements
|
250000 | |
| CY2014Q3 | biol |
No Individual Country Other Than United States Represents More Than Ten Percentage Of Net Revenue
NoIndividualCountryOtherThanUnitedStatesRepresentsMoreThanTenPercentageOfNetRevenue
|
No individual country, other than the United States, represented more than 10% of total net revenue. | |
| CY2013Q3 | biol |
No Individual Country Other Than United States Represents More Than Ten Percentage Of Net Revenue
NoIndividualCountryOtherThanUnitedStatesRepresentsMoreThanTenPercentageOfNetRevenue
|
No individual country, other than the United States, represented more than 10% of total net revenue. | |
| biol |
No Individual Country Other Than United States Represents More Than Ten Percentage Of Net Revenue
NoIndividualCountryOtherThanUnitedStatesRepresentsMoreThanTenPercentageOfNetRevenue
|
No individual country, other than the United States, represented more than 10% of total net revenue. | ||
| biol |
No Individual Country Other Than United States Represents More Than Ten Percentage Of Net Revenue
NoIndividualCountryOtherThanUnitedStatesRepresentsMoreThanTenPercentageOfNetRevenue
|
No individual country, other than the United States, represented more than 10% of total net revenue. | ||
| CY2014Q3 | us-gaap |
Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
|
0 | |
| us-gaap |
Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
|
0 | ||
| CY2013Q3 | us-gaap |
Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
|
0 | |
| us-gaap |
Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
|
1000 | ||
| CY2013Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.0054 | |
| us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0197 | ||
| CY2014Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.0080 | |
| biol |
Income Tax Reconciliation Tax Credits Alternative Minimum Tax And Research And Development
IncomeTaxReconciliationTaxCreditsAlternativeMinimumTaxAndResearchAndDevelopment
|
107000 | ||
| us-gaap |
Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
|
214000 | ||
| CY2013Q3 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | |
| us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | ||
| CY2014Q3 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 |
